alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Dan M. Berkovitz 

General Counsel 

Jonathan L. Marcus 

Deputy General Counsel 

Robert B. Wasserman 

Chief Counsel, Division of Clearing and Risk 

Martin B. White 

Assistant General Counsel 

Robert A. Schwartz 

Assistant General Counsel 

U.S. COMMODITY FUTURES TRADING COMMISSION 

Three Lafayette Plaza 

1155 21st Street N.W. 

Washington, DC 20581 

(202) 418-5000 

rschwartz@cftc.gov 

UNITED STATES DISTRICT COURT 

SOUTHERN DISTRICT OF NEW YORK 

CONOCOPHILLIPS COMPANY, et al., 

Plaintiffs, 

v. 

JAMES W. GIDDENS, Trustee for the SIPA 

Liquidation of MF Global, Inc., 

Defendant. 

Case No. 1:12-cv-06014-KBF 

NOTICE OF UNOPPOSED MOTION TO INTERVENE 

TO THE UNITED STATES DISTRICT COURT 

FOR THE SOUTHERN DISTRICT OF NEW YORK: 

 PLEASE TAKE NOTICE that, upon the accompanying Memorandum of Law of the 

Commodity Futures Trading Commission in Support of Its Unopposed Motion to Intervene, the 

Case 1:12-cv-06014-KBF Document 28 Filed 10/19/12 Page 1 of 3
2 

U.S. Commodity Futures Trading Commission hereby respectfully moves, pursuant to Federal 

Rules of Civil Procedure 24(a)(2) and (b)(2), to intervene in the above-captioned matter. The 

original parties to this action have indicated that they do not oppose the relief requested herein. 

Respectfully submitted, 

 COMMODITY FUTURES TRADING COMMISSION 

By: /s/ Robert A. Schwartz 

Dan M. Berkovitz, General Counsel 

Jonathan L. Marcus, Deputy General Counsel 

Robert B. Wasserman, 

 Chief Counsel, Division of Clearing and Risk 

Martin B. White, Assistant General Counsel 

Robert A. Schwartz, Assistant General Counsel 

 

U.S. Commodity Futures Trading Commission 

Three Lafayette Plaza 

1155 21st Street N.W. 

Washington, DC 20581 

(202) 418-5000 

jmarcus@cftc.gov 

rwasserman@cftc.gov 

mwhite@cftc.gov 

rschwartz@cftc.gov 

Dated: October 19, 2012

Case 1:12-cv-06014-KBF Document 28 Filed 10/19/12 Page 2 of 3
CERTIFICATE OF SERVICE

 I hereby certify that on October 19, 2012, I caused the foregoing document to be served 

on all counsel via the Court’s CM/ECF system. 

 /s/Robert A. Schwartz 

 Robert A. Schwartz 

 Assistant General Counsel

U.S. Commodity Futures Trading Commission 

Three Lafayette Plaza 

1155 21st Street N.W. 

Washington, DC 20581 

(202) 418-5958 

rschwartz@cftc.gov 

Case 1:12-cv-06014-KBF Document 28 Filed 10/19/12 Page 3 of 3
----

Corrigendum to Council Directive 98/20/EC of 30 March 1998 amending Directive 92/14/EEC on the limitation of the operation of aeroplanes covered by Part II, Chapter 2, Volume 1 of Annex 16 to the Convention on International Civil Aviation, second edition (1988)

(Official Journal of the European Communities L 107 of 7 April 1998)

On page 6, in the first sentence of Article 2:

for:

                  ‘Member States shall lay down the system of penalties for breaching the national provisions adopted pursuant to this Directive and shall take all the measures necessary to ensure that those penalties are applied.’,

read:

                  ‘Member States shall lay down the system of penalties for breaching the national provisions adopted in order to comply with Directive 92/14/EEC and shall take all the measures necessary to ensure that those penalties are applied.’.

----
James STROUSE, petitioner, v. K. KIDDY, et al.

No. 16-5848.

Supreme Court of the United States

Nov. 7, 2016.

Motion of petitioner for leave to proceed *in forma pauperis* denied, and petition for *449writ of certiorari dismissed. See Rule 39.8.
BULK TRANSPORT CORP., petitioner, v. CENTRAL STATES, SOUTHEAST AND SOUTHWEST AREAS PENSION FUND, et al.

No. 16-457.

Supreme Court of the United States

Oct. 31, 2016.

Petition for writ of certiorari to the United States Court of Appeals for the Seventh Circuit denied.
CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002


         In  connection  with the Annual  Report on Form 10-K for the year ended
September  30, 2004 (the  "Report") of Tech Holding  Company (the  "Company") as
filed with the  Securities  and  Exchange  Commission  on the date  hereof,  we,
Patrick O. Little,  President and Chief  Executive  Officer,  and J. L. Chauvin,
Vice President and Treasurer, certify, pursuant to 18 U.S.C. ss.1350, as adopted
pursuant to ss.906 of the Sarbanes-Oxley Act of 2002, that:

         (1) The Report fully complies with the requirements of Section 13(a) of
the Securities Exchange Act of 1934; and

         (2) The  information  contained in the Report fairly  presents,  in all
material  respects,  the  financial  condition  and results of operations of the
Company.


<TABLE>
<CAPTION>
<S>                                     <C>

/s/Patrick O. Little                       /s/J. L. Chauvin
-------------------------------------      ----------------------------
Patrick O. Little                          J. L. Chauvin
President and Chief Executive Officer      Vice President and Treasurer
                                           (Principal Financial and Accounting Officer)

December 29, 2004


</TABLE>
**EXHIBIT 99.1**

 

**CERTIFICATION PURSUANT TO**

**18 U.S.C. SECTION 1350,**

**AS ADOPTED PURSUANT TO**

**SECTION 906 OF THE SARBANES-OXLEY ACT OF2002**

 

In connection with the Annual Report ofDigital Generation Systems, Inc. (the “Company”) on Form 10-K for the period ending December 31, 2002 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), the undersigned, in the capacities anddates indicated below, hereby certify pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, to the best of my knowledge that: 

 

(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Actof 1934; and 

 

(2) The information contained inthe Report fairly presents, in all material respects, the financial condition and results of operations of the Company. 

 

/S/ MATTHEW E. DEVINE

Matthew E.Devine 

Chief Executive Officer 

 

/S/ OMAR A. CHOUCAIR

Omar A. Choucair

Chief Executive Officer 

 

March 27, 2003
IV 

111TH CONGRESS 

2D SESSION H. RES. 1311 

Expressing support for the charitable collection and good samaritan distribution to uninsured, low-income Americans of Food and Drug Administration-approved, medically appropriate, non-expired, non-narcotic prescription medications by non-profit organizations licensed to dispense such 

medications. 

IN THE HOUSE OF REPRESENTATIVES 

APRIL 29, 2010 

Mr. COHEN (for himself and Mr. FARR) submitted the following resolution; 

which was referred to the Committee on Energy and Commerce, and in 

addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such 

provisions as fall within the jurisdiction of the committee concerned 

RESOLUTION 

Expressing support for the charitable collection and good 

samaritan distribution to uninsured, low-income Americans of Food and Drug Administration-approved, medically appropriate, non-expired, non-narcotic prescription 

medications by non-profit organizations licensed to dispense such medications. 

Whereas millions of Americans are uninsured or underinsured; 

Whereas millions of Americans struggle daily to manage their 

health including serious chronic diseases like asthma, diabetes, heart disease, cancer, stroke, and arthritis; 


jbell on DSKDVH8Z91PROD with BILLS
2 

•HRES 1311 IH 

Whereas over 100,000,000 Americans have incomes below 

200 percent of the Federal poverty level and cannot afford essential medications; 

Whereas billions of dollars worth of in-date, usable medicine 

is unnecessarily wasted in the United States health care 

system each year; and 

Whereas pharmaceutical manufacturers’ humanitarianism 

and philanthropy expresses itself in billions of dollars annually in medication that assists low-income Americans: 

Now, therefore, be it 

1 Resolved, That the House of Representatives— 

2 (1) encourages pharmaceutical manufacturers, 

3 health care professionals, and institutions providing 

4 health care to make charitable donations of Food 

5 and Drug Administration-approved, medically appro6 priate, non-expired, non-narcotic prescription medi7 cations to non-profit organizations whose primary 

8 mission is to fill prescriptions for low-income Ameri9 cans; 

10 (2) supports exempting pharmaceutical compa11 nies from civil or criminal liability arising from the 

12 donation of medications that the pharmaceutical 

13 companies donate in good faith to non-profit organi14 zations for ultimate distribution to needy individuals, 

15 assuming there is no gross negligence or intentional 

16 misconduct on the part of the pharmaceutical com17 pany; and 


jbell on DSKDVH8Z91PROD with BILLS
3 

•HRES 1311 IH 

1 (3) encourages the Secretary of the Department 

2 of Health and Human Services to convene a working 

3 group of appropriate officers and employees of the 

4 Department of Health and Human Services to de5 velop plans to facilitate the creation and operation of 

6 non-profit organizations able to achieve the goals of 

7 this resolution. 

Æ 


jbell on DSKDVH8Z91PROD with BILLS
[Federal Register Volume 66, Number 115 (Thursday, June 14, 2001)]
[Notices]
[Pages 32359-32360]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 01-14929]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration


Orally Inhaled and Nasal Drug Products Subcommittee of the 
Advisory Committee for Pharmaceutical Science; Notice of Meeting

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

    This notice announces a forthcoming meeting of a public advisory 
committee of the Food and Drug Administration

[[Page 32360]]

(FDA). The meeting will be open to the public.
    Name of Committee: Orally Inhaled and Nasal Drug Products 
Subcommittee of the Advisory Committee for Pharmaceutical Science.
    General Function of the Committee: To provide advice and 
recommendations to the agency on FDA's regulatory issues.
    Date and Time: The meeting will be held on July 17, 2001, from 8:30 
a.m. to 5:30 p.m.
    Location: Center for Drug Evaluation and Research Advisory 
Committee conference room 1066, 5630 Fishers Lane, Rockville, MD.
    Contact: Nancy Chamberlin, Center for Drug Evaluation and Research 
(HFD-21), Food and Drug Administration, 5600 Fishers Lane (for express 
delivery, 5630 Fishers Lane, rm. 1093) Rockville, MD 20857, 301-827-
7001, or e-mail: <a href="/cdn-cgi/l/email-protection#b1f2f9f0fcf3f4e3fdf8fffff1d2d5d4c39fd7d5d09fd6dec7"><span class="__cf_email__" data-cfemail="9ad9d2dbd7d8dfc8d6d3d4d4daf9feffe8b4fcfefbb4fdf5ec">[email protected]</span></a>, or FDA Advisory Committee 
Information Line, 1-800-741-8138 (301-443-0572 in the Washington, DC 
area), code 12539. Please call the Information Line for up-to-date 
information on this meeting.
    Agenda: The subcommittee meeting will discuss the issue of dose-
response of locally acting nasal sprays and nasal aerosols, with 
particular application to bioequivalence studies.
    Procedure: Interested persons may present data, information, or 
views, orally or in writing, on issues pending before the committee. 
Written submissions may be made to the contact person by July 10, 2001. 
Oral presentations from the public will be scheduled between 
approximately 11:30 a.m. to 12:30 p.m. Time allotted for each 
presentation may be limited. Those desiring to make formal oral 
presentations should notify the contact person before July 10, 2001, 
and submit a brief statement of the general nature of the evidence or 
arguments they wish to present, the names and addresses of proposed 
participants, and an indication of the approximate time requested to 
make their presentation.
    Notice of this meeting is given under the Federal Advisory 
Committee Act (5 U.S.C. app. 2).

    Dated: June 6, 2001.
Linda A. Suydam,
Senior Associate Commissioner.
[FR Doc. 01-14929 Filed 6-13-01; 8:45 am]
BILLING CODE 4160-01-S


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
UNPUBLISHED

UNITED STATES COURT OF APPEALS

FOR THE FOURTH CIRCUIT

UNITED STATES OF AMERICA, 

Plaintiff-Appellee,

v.  No. 01-4247

SHAUN AUTALEON POSTON, a/k/a

Shawn Autaleon Poston,

Defendant-Appellant. 

Appeal from the United States District Court

for the Western District of North Carolina, at Statesville.

Richard L. Voorhees, District Judge.

(CR-99-12)

Submitted: January 14, 2002

Decided: February 1, 2002

Before WILLIAMS and KING, Circuit Judges, and

HAMILTON, Senior Circuit Judge.

Affirmed by unpublished per curiam opinion. 

COUNSEL

Mark P. Foster, Jr., Charlotte, North Carolina, for Appellant. Robert

J. Conrad, Jr., United States Attorney, Gretchen C. F. Shappert, Assistant United States Attorney, Charlotte, North Carolina, for Appellee.
Unpublished opinions are not binding precedent in this circuit. See

Local Rule 36(c). 

OPINION

PER CURIAM: 

Shaun Autaleon Poston was charged in a one-count superseding

indictment with conspiracy to possess with intent to distribute cocaine

and cocaine base in violation of 21 U.S.C.A. §§ 841(a)(1),

841(b)(1)(A)(ii), 841(b)(1)(A)(iii), 846 (West 1999). Poston was convicted following a jury trial and sentenced to 360 months in prison

and five years of supervised release. Because we find no reversible

error, we affirm. 

On appeal, Poston argues: (1) the evidence presented at trial was

insufficient to support his conviction; (2) the district court improperly

concluded he was responsible for in excess of 1.5 kilograms of

cocaine base; and (3) a two-level enhancement was not warranted

because there was insufficient evidence that he possessed a dangerous

weapon. We review the verdict to determine "whether ‘there is substantial evidence, taking the view most favorable to the government,’

to support the conviction." United States v. Ismail, 97 F.3d 50, 55 (4th

Cir. 1996) (quoting Glasser v. United States, 315 U.S. 60, 80 (1942)).

We do not review a witness’s credibility in assessing whether the evidence was sufficient to support a conviction. United States v. Hobbs,

136 F.3d 384, 391 n.11 (4th Cir. 1998). We have reviewed the evidence presented at trial and, when taken in the light most favorable

to the Government, we conclude the evidence is sufficient to support

Poston’s conviction. 

We review the district court’s factual findings regarding Poston’s

sentencing for clear error and its application of the sentencing guidelines de novo. United States v. Daughtrey, 874 F.2d 213, 217 (4th Cir.

1989). We have reviewed the district court’s findings and have found

no error. Accordingly, we affirm Poston’s conviction and sentence.

We dispense with oral argument because the facts and legal contentions are adequately presented in the materials before the court and

argument would not aid the decisional process.

AFFIRMED

2 UNITED STATES v. POSTON
John CARTER, petitioner, v. INDEPENDENCE SEAPORT MUSEUM.

No. 16-5674.

Supreme Court of the United States

Oct. 31, 2016.

Petition for writ of certiorari to the United States Court of Appeals for the First Circuit denied.
<TABLE> <S> <C>

<ARTICLE> 5
       
<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-1996
<PERIOD-START>                             JAN-01-1996
<PERIOD-END>                               SEP-30-1996
<CASH>                                         193,684
<SECURITIES>                                         0
<RECEIVABLES>                                      760
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                               271,460
<PP&E>                                       7,552,225
<DEPRECIATION>                               1,784,427
<TOTAL-ASSETS>                               6,039,258
<CURRENT-LIABILITIES>                          206,413
<BONDS>                                      3,000,000
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                             0
<OTHER-SE>                                   2,832,845
<TOTAL-LIABILITY-AND-EQUITY>                 6,039,258
<SALES>                                        890,755
<TOTAL-REVENUES>                               954,071
<CGS>                                                0
<TOTAL-COSTS>                                  700,255
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                             186,687
<INCOME-PRETAX>                                 67,129
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                             67,129
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                    67,129
<EPS-PRIMARY>                                     5.24
<EPS-DILUTED>                                     5.24
        

</TABLE>
nk-ex101_452.htm



 

Exhibit 10.1

 



 

April 7, 2016

 

PERSONAL AND CONFIDENTIAL 

 

Sonja Nelson

 

Re: Promotion   

 

Dear Sonja, 

 

We are pleased to inform you that subject to the approval of the Company’s board of directors, your title will be Vice President, Corporate Controller and Chief Accounting Officer.  You will receive a salary increase to an annual rate of $245,000 effective April 1, 2016. This salary will be paid in accordance with the Company’s regularly established payroll practice. The salary hereof is a gross amount, and the Company will be required to withhold from such amount deductions with respect to Federal, state and local taxes, FICA, unemployment compensation taxes and similar taxes, assessments or withholding requirements. You will continue to report to Richard Tajak, Chief Financial Officer.

 

I look forward to your continued growth within our organization. If you should have any questions, please contact me at nantoniou@nantworks.com or 310-853-7812

 

Sincerely,

 

/s/ Nancy Valdivia Antoniou

 

Nancy Valdivia Antoniou 

Human Resources

 

cc:  Personnel File 

 

NantKwest Inc. | 9920 Jefferson Blvd, Culver City, CA 90232 

www.nantkwest.com
_______________________________________ __ Michigan Supreme Court 

# Order

Lansing, Michigan

November 29, 2007 Clifford W. Taylor,
Chief Justice

Michael F. Cavanagh
Elizabeth A. Weaver 134000 Marilyn Kelly Maura D. Corrigan Robert P. Young, Jr. Stephen J. Markman, PEOPLE OF THE STATE OF MICHIGAN, Justices Plaintiff-Appellee,

v SC: 134000 COA: 267261 Wayne CC: 05-009294-01 GUY ALLEN SALLIS, Defendant-Appellant.

________________ _______________ __________/

On order of the Court, the application for leave to appeal the April 17, 2007 judgment of the Court of Appeals is consid ered, and it is DENIED, because we are not persuaded that the questions presented should be reviewed by this Court.

d1119 I, Corbin R. Davis, Clerk of the Mi chigan Supreme Cour t, certify that the foregoing is a true and complete copy of the order entered at the direction of the Court.

November 29, 2007

Clerk
<TABLE> <S> <C>


<ARTICLE> 5
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   12-MOS
<FISCAL-YEAR-END>                          DEC-31-1999
<PERIOD-START>                             JAN-01-1999
<PERIOD-END>                               DEC-31-1999
<CASH>                                           1,635
<SECURITIES>                                         0
<RECEIVABLES>                                    4,107
<ALLOWANCES>                                       495
<INVENTORY>                                      2,316
<CURRENT-ASSETS>                                12,267
<PP&E>                                           2,541
<DEPRECIATION>                                   1,027
<TOTAL-ASSETS>                                  21,585
<CURRENT-LIABILITIES>                           20,515
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                     20,861
<COMMON>                                            85
<OTHER-SE>                                    (22,568)
<TOTAL-LIABILITY-AND-EQUITY>                    21,585
<SALES>                                         28,271
<TOTAL-REVENUES>                                28,271
<CGS>                                           21,927
<TOTAL-COSTS>                                   21,927
<OTHER-EXPENSES>                                22,628
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                 574
<INCOME-PRETAX>                               (16,858)
<INCOME-TAX>                                         7
<INCOME-CONTINUING>                           (16,865)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                  (22,651)
<EPS-BASIC>                                     (2.84)
<EPS-DILUTED>                                   (2.84)


</TABLE>
Malvin PALMER, petitioner, v. UNITED STATES.

No. 16-6588.

Supreme Court of the United States

Nov. 28, 2016.

Petition for writ of certiorari to the United States Court of Appeals for the District of Columbia Circuit denied.
George WARREN, petitioner, v. UNITED STATES.

No. 16-6088.

Supreme Court of the United States

Jan. 9, 2017.

Petition for writ of certiorari to the United States Court of Appeals for the Tenth Circuit denied.
EXHIBIT 32.2


                           SECTION 1350 CERTIFICATION


     In connection with the Quarterly Report of Palmdale  Executive Homes, Corp.
(the  "Company") on Form 10-Q for the quarter ending June 30, 2009 as filed with
the Securities  and Exchange  Commission on the date hereof (the  "Report"),  I,
Tricia A. Nickson,  Secretary and Treasurer of the Company, certify, pursuant to
18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley
Act of 2002, that, to my knowledge:

     (1)  The Report fully  complies with the  requirements  of section 13(a) or
          15(d) of the Securities Exchange Act of 1934; and

     (2)  The  information  contained  in the  Report  fairly  presents,  in all
          material respects,  the financial  condition and results of operations
          of the Company.


Date: July 24, 2009



                                        By: /s/ TRICIA A. NICKSON
                                            ________________________________
                                                Tricia A. Nickson
                                                Secretary and Treasurer